School of Nursing, Weifang Medical University, Weifang, China.
Affiliated Hospital of Weifang Medical University, Weifang, China.
Medicine (Baltimore). 2024 Mar 1;103(9):e37326. doi: 10.1097/MD.0000000000037326.
Hashimoto thyroiditis (HT) is a common autoimmune thyroid disease for which there is no specific treatment. Oral levothyroxine sodium tablets significantly improved thyroid function but did not promote a reduction in thyroid-related antibody concentrations. Acupuncture can improve clinical symptoms and thyroid function in HT patients, reduce serum TPOAb and TGAb levels in HT patients, and improve patients' quality of life.
We conducted a systematic review and meta-analysis to evaluate the effect of acupuncture versus levothyroxine sodium tablets on Hashimoto thyroiditis. We searched Web of Science, Embase, China National Knowledge Infrastructure, WanFang, VIP, SinoMed and the Cochrane Central Registry of Controlled Trials to identify candidate randomized controlled trials (RCTs).
A total of 1020 patients participated in 14 randomized controlled trials. The results of meta-analysis showed that acupuncture regulated TPOAb content (mean difference [MD] = -63.18, 95%CI = -91.73 to -34.62, P < .00001), TGAb content (MD = -68.56, 95%CI = -101.55 to -35.57, P < .00001), serum free triiodothyronine (FT3) content (MD = 0.74, 95%CI = 0.20 to 1.27, P < .00001), serum free thyroxine (FT4) content (MD = 1.10, 95%CI = 0.29 to 1.92, P < .00001), TSH content (MD = -2.16, 95%CI = -3.14 to -1.19, P < .00001) had a significant effect.
Compared with levothyroxine sodium tablets alone, acupuncture can significantly regulate the contents of TPOAb, TGAb, FT3, FT4 and TSH.
桥本甲状腺炎(HT)是一种常见的自身免疫性甲状腺疾病,目前尚无特效治疗方法。口服左甲状腺素钠片可显著改善甲状腺功能,但不能降低甲状腺相关抗体浓度。针刺可以改善 HT 患者的临床症状和甲状腺功能,降低 HT 患者血清 TPOAb 和 TGAb 水平,提高患者生活质量。
我们系统地检索了 Web of Science、Embase、中国知网、万方、维普、中国生物医学文献数据库和 Cochrane 中央对照试验注册库,以评估针刺与左甲状腺素钠片治疗桥本甲状腺炎的效果。共纳入 14 项随机对照试验,纳入 1020 例患者。Meta 分析结果显示,针刺可调节 TPOAb 含量[均数差(MD)=-63.18,95%可信区间(CI)=-91.73 至-34.62,P<.00001]、TGAb 含量(MD=-68.56,95%CI=-101.55 至-35.57,P<.00001)、血清游离三碘甲状腺原氨酸(FT3)含量(MD=0.74,95%CI=0.20 至 1.27,P<.00001)、血清游离甲状腺素(FT4)含量(MD=1.10,95%CI=0.29 至 1.92,P<.00001)、促甲状腺激素(TSH)含量(MD=-2.16,95%CI=-3.14 至-1.19,P<.00001)。
与单纯左甲状腺素钠片相比,针刺治疗可显著调节 TPOAb、TGAb、FT3、FT4 和 TSH 的含量。